Nona Biosciences is a leading global biotechnology company dedicated to cutting edge technology innovations. We provide a total solution for partners worldwide, from academic institutions and biotech startups to major biopharmaceutical companies. Our integrated antibody discovery services range from antigen preparation, animal immunization and single B cell screening, to antibody lead generation and engineering, developability assessment and pharmacological evaluation. Our advanced antibody discovery engine leverages the unique advantages of our proprietary Harbour Mice® platforms and our highly experienced therapeutic antibody discovery team. Our cutting-edge Harbour Mice® platform generates fully human monoclonal antibodies in two heavy and two light chains (H2L2) format, as well as heavy chain only (HCAb) format. By integrating Harbour Mice® and the Beacon® single B cell screening platform, Nona Biosciences is committed to driving global inventions of transformative next-generation drugs through diversified partnership strategies. The value and effectiveness of our antibody discovery platforms and our flexible partnership models have been extensively validated.